Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celgene provides regulatory update on lenalidomide and pomalidomide

June 22, 2012

OncoEthix in-licenses product from Mitsubishi Tanabe Pharma

June 22, 2012

Oncomatrix and National Jewish Health join forces to treat invasive tumors

June 22, 2012

Novel diagnostics for cancer disclosed by French team

June 22, 2012

FDA advisory committee votes on carfilzomib NDA

June 21, 2012

Data monitoring committee recommends continued enrollment in Reolysin trial

June 21, 2012

FDA grants orphan drug status to new therapy for AML

June 21, 2012

Pharmacokinetics of pure icaritin investigated in rats

June 21, 2012

Merck KGaA prepares novel protein kinase inhibitors

June 21, 2012

First clinical data disclosed on Genzyme DNA topoisomerase I inhibitor

June 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...